New initiative seeks to improve clinical trials, develop novel analgesics
Drug UPDATES
Information on New Approvals and Medication Safety
Drug UPDATES
Information on New Approvals and Medication Safety
Pharma awaits FDA Guidance to Navigate the Murky Waters of Ads Via the Internet and Social Media
There’s no question that direct-to-consumer (DTC) advertising of prescription drugs is a huge activity, with nearly $5 billion spent on DTC ads in 2007. There’s also no question that the Internet has a vast potential to reach consumers. But when you put DTC advertising and the Internet together, there is a potential for problems and…
Colcrys Approval Triggers Questions
Some rheumatologists question the depth of research and the approval’s implications for patient access
Drug Updates
Information on News Approvals and Medication Safety
Drug Updates
Information on New Approvals and Medication Safety
REMS Required
How will this FDA drug safety program affect rheumatology offices?
Drug Risk Versus Benefit
Perceptions from the FDA, physicians, and patients
A Regulatory Leader in Rheumatology
Jeffrey Siegel, MD: A rare combination of clinical scientist and regulatory collaborator